Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    GHDr. Gabriela Hobbs

    Dr. Gabriela Hobbs

    Hematology & Oncology · Leukemia
    Mass General Brigham
    gabriela

    Research

    Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis

    2023

    Via Bone Marrow Transplantation

    Research

    Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial

    2023

    Via Cancer

    Research

    Author's reply

    2023

    Via Journal of Cardiology

    Research

    Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms

    2023

    Via Hematology Reports

    Research

    Incidence of bleeding events in patients on concomitant tyrosine kinase inhibitors and selective serotonin reuptake inhibitors

    2022

    Via Journal of Oncology Pharmacy Practice

    Research

    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation

    2022

    Via Journal of Cardiology

    Research

    Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.

    2020

    Via Blood Advances

    Research

    A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia.

    2020

    Via Blood Advances

    Research

    Antiemetic prophylaxis for induction chemotherapy in patients with acute myeloid leukemia.

    2020

    Via Journal of Oncology Pharmacy Practice

    Research

    Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia.

    2020

    Via Blood Advances

    Research

    A Practical Guide for Using Myelofibrosis Prognostic Models in the Clinic.

    2020

    Via Journal of the National Comprehensive Cancer Network (JNCCN)

    Research

    Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission.

    2019

    Via Cancer

    Research

    Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes.

    2019

    Via Leukemia & Lymphoma

    Research

    Mutant calreticulin in myeloproliferative neoplasms.

    2019

    Via Blood

    Research

    Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.

    2019

    Via The Lancet Haematology